Many multinational drug companies use India and other developing companies for clinical trials, but domestic drug major Nicholas Piramal has decided to conduct this trial for the first time in the US for its breakthrough blood cancer drug.
Many multinational drug companies use India and other developing companies for clinical trials, but domestic drug major Nicholas Piramal has decided to conduct this trial for the first time in the US for its breakthrough blood cancer drug.
